Autologous lymphocytes therapy(Biohealthcare)

自体淋巴细胞疗法(康爱瑞浩)

Report date: 2026/03/04 20:01:44

Base Information

Drug NameAutologous lymphocytes therapy(Biohealthcare)
Drug Alias Name自体淋巴细胞注射液KACM-001
ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy
Mechanisms of ActionImmunostimulantsGene transference
TargetsNot applicable
Therapy Area/IndicationsStomach NeoplasmsCarcinoma, Hepatocellular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Inactive CompaniesN/A
Active IndicationsStomach NeoplasmsCarcinoma, Hepatocellular
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A